Dr. Melania Montes, PhD

Dr. Melania Montes, PhD

Dr. Melania Montes, PhD

Scientific Reviewer — Mito Red Light

Vall d'Hebron Institute of Research (VHIR), PhD · Visiting Researcher, UC Berkeley

Credentials & Institutional Affiliations

  • PhD, Biomedical Research — Vall d'Hebron Institute of Research (VHIR), Barcelona · Dissertation: MicroRNAs as Predictors and Therapy for Prostate Cancer
  • Visiting Researcher — University of California, Berkeley · Research focus: metabolic vulnerabilities in colorectal cancer; lipid metabolism and oxidative stress as therapeutic targets
  • Research Specializations: Cellular and Molecular Biology, Gene Expression Analysis, NF-κB Signaling Pathway, Oxidative Stress, Reactive Oxygen Species (ROS), MicroRNAs, Exosomes, Liquid Biopsies, Diagnostic and Prognostic Biomarkers, Cell-Based Assays for Drug Testing

About Dr. Montes

Dr. Melania Montes is a biomedical researcher with a PhD from the Vall d'Hebron Institute of Research (VHIR) in Barcelona, one of Europe's leading translational research institutions affiliated with the Vall d'Hebron University Hospital. Her doctoral research focused on the role of microRNAs in prostate cancer — investigating their utility as biomarkers for detection and prognosis, and exploring their potential as targets for gene expression-based therapeutic strategies.

As a Visiting Researcher at the University of California, Berkeley, Dr. Montes has extended her work into metabolic biology, with a particular focus on how lipid metabolism and oxidative stress can be leveraged to improve therapeutic outcomes in colorectal cancer. This research directly engages the molecular mechanisms — including reactive oxygen species (ROS), NF-κB pathway activation, and cellular energy metabolism — that are central to understanding how light-based therapies interact with biological tissue at the cellular level.

Her expertise in cellular and molecular biology, oxidative stress pathways, and cell-based assay methodology provides a rigorous scientific foundation for evaluating the evidence base for blue light therapy. Blue light's primary therapeutic mechanisms in skin — including its effects on Cutibacterium acnes via porphyrin-mediated ROS production, its modulation of inflammatory cytokines through NF-κB signaling, and its influence on sebaceous gland activity — are directly within the scope of Dr. Montes' research background.

At Mito Red Light, Dr. Montes serves as a scientific reviewer for content covering blue light therapy, skin health, acne, and related dermatological applications of photobiomodulation.

Relevance to Blue Light Therapy Review

The scientific mechanisms underlying blue light therapy for skin involve the same cellular and molecular pathways that Dr. Montes studies in her primary research:

  • Reactive Oxygen Species (ROS) — Blue light (415nm) activates endogenous porphyrins in Cutibacterium acnes, generating ROS that selectively damage acne-causing bacteria. Dr. Montes' research expertise includes oxidative stress and ROS-mediated cellular effects.
  • NF-κB Signaling — Blue light modulates the NF-κB inflammatory pathway in skin cells, reducing pro-inflammatory cytokine production. NF-κB pathway research is listed as a core competency of Dr. Montes.
  • Cell-Based Assay Methodology — Her experience with in vitro functional assays and cell-based drug testing provides methodological rigor for evaluating clinical evidence in blue light therapy research.
  • Gene Expression Modulation — Therapeutic strategies based on gene expression modulation are central to both her cancer research and the mechanism by which photobiomodulation influences skin cell behavior.

Mito Red Light Content Reviewed by Dr. Montes

The following articles have been scientifically reviewed by Dr. Melania Montes, PhD for accuracy of blue light therapy mechanisms, clinical evidence interpretation, and skin biology claims:

External Profiles